ZYMENEX ApS: Financial statements 2015
CVR: 27394752
Source: annual report 2015, Danish Business Authority
01/01/2015 – 31/12/2015
ZYMENEX ApS (CVR 27394752) has filed annual accounts for 2015. In 2015, the company reported a gross profit of DKK -52,501,446 and a net result of DKK 656,421 compared with DKK 1,065,781 the year before. Equity in the 2015 report amounted to DKK -64,099,563.
- Gross Profit
- DKK -52,501,446
- Profit/Loss
- DKK 656,421
- Equity
- DKK -64,099,563
- Total Assets
- DKK 17,954,460
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2015 | - | -52.5 mio. | 656 t. | -64.1 mio. | - |
| 2014 | - | -67.9 mio. | 1.1 mio. | -64.8 mio. | - |
| 2013 | - | - | -33.8 mio. | -65.8 mio. | - |
| 2012 | - | - | -42 mio. | -32.1 mio. | - |
Official annual report
How creditworthy is ZYMENEX ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2015
As of November 1, 2015, Natallia Misuna has joined the board of directors of ZYMENEX ApS.
As of November 1, 2015, Claes Magnus Andersson has joined the board of directors of ZYMENEX ApS.
As of November 1, 2015, Paolo Patri has joined the board of directors of ZYMENEX ApS.
As of November 1, 2015, Danilo Piroli has left the board of directors of ZYMENEX ApS.
As of November 1, 2015, Jens Morten Fogh is registered as chairman of ZYMENEX ApS.
As of November 1, 2015, Paolo Patri is registered as director of ZYMENEX ApS.
As of November 1, 2015, Jens Morten Fogh has stepped down as direktion of ZYMENEX ApS.
As of November 1, 2015, Mark Parry-Billings has stepped down as chairman of ZYMENEX ApS.
As of October 31, 2015, Jens Morten Fogh has left the board of directors of ZYMENEX ApS.
ZYMENEX ApS has published its annual report for 2014. Gross profit came to DKK -67,882,459, and the net result was DKK 1,065,781.
About ZYMENEX ApS
ZYMENEX ApS was a Danish company of the type Anpartsselskab based in København Ø, founded in 2003. The company has been dissolved on 11 September 2019. The company was registered under the industry Forskning og eksperimentel udvikling indenfor bioteknologi. The company has 1 employee (2018). In 2018, the company reported revenue of DKK 10,758,000 and a net result of DKK 1,292,000 compared with DKK 3,404,000 the year before. Equity in the 2018 report amounted to DKK 82,550,000.